Jazz Pharmaceuticals

JAZZNasdaq Ireland Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$16.654 B

$256.56 -0.04%

Close of 7 Aug 2026

Revenue

$4.27B

#747 by revenue

Earnings

-$356.1M

Loss-making

Shares outstanding

64,914,577

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#23United TherapeuticsUTHR$23.1B
#24ViatrisVTRS$19.1B
#25Jazz PharmaceuticalsJAZZ$16.7B
#26BridgeBio PharmaBBIO$16.5B
#27Ascendis Pharma A/SASND$15.8B

Where these numbers come from

Share counts and financials for Jazz Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.